DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Children's Cetirizine Hydrochloride Hives Relief is a drug marketed by Actavis Mid Atlantic, Amneal Pharms, Athem, Aurobindo Pharma, Cypress Pharm, Lannett Co Inc, Perrigo R And D, Pharm Assoc, Ranbaxy Labs Ltd, Taro, Torrent, Tris Pharma Inc, Jubilant Generics, and Sun Pharm. and is included in fifteen NDAs.
The generic ingredient in CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and thirty-six suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
A generic version of CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF was approved as cetirizine hydrochloride by TEVA PHARMS on May 27th, 2008.
Summary for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
Recent Clinical Trials for CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
Identify potential brand extensions & 505(b)(2) entrants
|Hamad Medical Corporation||Phase 1|
|Stefania La Grutta, MD||Phase 4|
|Medical Universtity of Lodz||Phase 4|